no statement of use filed
on 12 Sep 2022
Last Applicant/ Owned by
7 Fl., No.368, Sec.1, Fu-Hsing South Rd.
Taipei
TW
Serial Number
90318022 filed on 13th Nov 2020
Registration Number
N/A
Correspondent Address
Nicole B. Rackiewicz
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMA"
The mark consists of the stylized words "OEP Pharma" to the right of a miscellaneous design having an overall diamond shape. Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuRead More
Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents
No 90318022
No Service/Collective Mark
No MR3575-227
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.07.28 -
Miscellaneous designs with overall diamond shape, including letters forming or comprising a diamond
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
The mark consists of the stylized words "OEP Pharma" to the right of a miscellaneous design having an overall diamond shape.
| Status Date | Action Taken |
|---|---|
| 12th Sep 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 12th Sep 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 01st Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Jan 2022 | SOU EXTENSION 1 GRANTED |
| 28th Jan 2022 | SOU EXTENSION 1 FILED |
| 28th Jan 2022 | TEAS EXTENSION RECEIVED |
| 10th Aug 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 15th Jun 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Jun 2021 | PUBLISHED FOR OPPOSITION |
| 26th May 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
